$REGN REGENERON PHARMACEUTICALS, INC. Insider Trading Week 24/2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in REGENERON PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in REGENERON PHARMACEUTICALS, INC. in week 24/2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 16 2017 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Option Exercise | M | 21.25 | 20,295 | 431,269 | 0 | |
| Jun 16 2017 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 474.48 | 100 | 47,448 | 23,950 | 24.1 K to 24 K (-0.42 %) |
| Jun 16 2017 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 472.95 | 100 | 47,295 | 24,050 | 24.2 K to 24.1 K (-0.41 %) |
| Jun 16 2017 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 471.15 | 100 | 47,115 | 24,150 | 24.3 K to 24.2 K (-0.41 %) |
| Jun 16 2017 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 470.57 | 2,426 | 1,141,603 | 24,250 | 26.7 K to 24.3 K (-9.09 %) |
| Jun 16 2017 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 469.53 | 2,212 | 1,038,600 | 26,676 | 28.9 K to 26.7 K (-7.66 %) |
| Jun 16 2017 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 468.63 | 900 | 421,767 | 28,888 | 29.8 K to 28.9 K (-3.02 %) |
| Jun 16 2017 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 467.82 | 300 | 140,346 | 29,788 | 30.1 K to 29.8 K (-1.00 %) |
| Jun 16 2017 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 466.52 | 185 | 86,306 | 30,088 | 30.3 K to 30.1 K (-0.61 %) |
| Jun 16 2017 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 465.49 | 1,244 | 579,070 | 30,273 | 31.5 K to 30.3 K (-3.95 %) |
| Jun 16 2017 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 464.69 | 400 | 185,876 | 31,517 | 31.9 K to 31.5 K (-1.25 %) |
| Jun 16 2017 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 463.91 | 100 | 46,391 | 31,917 | 32 K to 31.9 K (-0.31 %) |
| Jun 16 2017 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 462.72 | 500 | 231,360 | 32,017 | 32.5 K to 32 K (-1.54 %) |
| Jun 16 2017 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Payment of Exercise | F | 475.56 | 10,822 | 5,146,510 | 32,517 | 43.3 K to 32.5 K (-24.97 %) |
| Jun 16 2017 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Payment of Exercise | F | 475.56 | 906 | 430,857 | 43,339 | 44.2 K to 43.3 K (-2.05 %) |
| Jun 16 2017 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Buy | M | 21.25 | 20,295 | 431,269 | 44,245 | 24 K to 44.2 K (+84.74 %) |
| Jun 14 2017 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Option Exercise | M | 177.82 | 2,000 | 355,640 | 6,000 | |
| Jun 14 2017 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Sell | S | 475.72 | 606 | 288,286 | 0 | 606 to 0 (-100.00 %) |
| Jun 14 2017 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Sell | S | 474.37 | 900 | 426,933 | 606 | 1.5 K to 606 (-59.76 %) |
| Jun 14 2017 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Sell | S | 473.37 | 200 | 94,674 | 1,506 | 1.7 K to 1.5 K (-11.72 %) |
| Jun 14 2017 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Sell | S | 469.02 | 94 | 44,088 | 1,706 | 1.8 K to 1.7 K (-5.22 %) |
| Jun 14 2017 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Sell | S | 477.05 | 100 | 47,705 | 1,800 | 1.9 K to 1.8 K (-5.26 %) |
| Jun 14 2017 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Sell | S | 472.04 | 100 | 47,204 | 1,900 | 2 K to 1.9 K (-5.00 %) |
| Jun 14 2017 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Buy | M | 177.82 | 2,000 | 355,640 | 2,000 | 0 to 2 K |
| Jun 13 2017 | REGN | REGENERON PHARMACE ... | GOLDSTEIN JOSEPH L | Director | Option Exercise | M | 273.67 | 1,000 | 273,670 | 7,500 | |
| Jun 13 2017 | REGN | REGENERON PHARMACE ... | GOLDSTEIN JOSEPH L | Director | Sell | S | 482.55 | 1,000 | 482,550 | 13,000 | 14 K to 13 K (-7.14 %) |
| Jun 13 2017 | REGN | REGENERON PHARMACE ... | GOLDSTEIN JOSEPH L | Director | Buy | M | 273.67 | 1,000 | 273,670 | 14,000 | 13 K to 14 K (+7.69 %) |